Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Deep neural networks are superior to dermatologists in melanoma image classification.

European journal of cancer (Oxford, England : 1990)·2019
Same author

Impact of American Joint Committee on Cancer 8th edition classification on staging and survival of patients with melanoma.

European journal of cancer (Oxford, England : 1990)·2019
Same author

Cardiovascular Adverse Events Associated With BRAF and MEK Inhibitors: A Systematic Review and Meta-analysis.

JAMA network open·2019
Same author

Deep learning outperformed 11 pathologists in the classification of histopathological melanoma images.

European journal of cancer (Oxford, England : 1990)·2019
Same author

Prognostic factors for pulmonary metastasectomy in malignant melanoma: size matters.

European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery·2019
Same author

Informations- und Hilfsangebote für Melanompatienten: Präferenzielle Unterschiede zwischen Patienten und Ärzten.

Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG·2019

Related Experiment Video

Updated: Apr 18, 2026

Detecting Somatic Genetic Alterations in Tumor Specimens by Exon Capture and Massively Parallel Sequencing
11:02

Detecting Somatic Genetic Alterations in Tumor Specimens by Exon Capture and Massively Parallel Sequencing

Published on: October 18, 2013

20.1K

Panel sequencing melanomas.

Klaus G Griewank1, Dirk Schadendorf1

  • 1West German Cancer Center, Department of Dermatology, University Hospital Essen, University Duisburg-Essen and the German Cancer Consortium (DKTK), Essen, Germany.

The Journal of Investigative Dermatology
|January 10, 2015
PubMed
Summary
This summary is machine-generated.

Clinical genetic analysis for metastatic melanoma is shifting from Sanger sequencing to targeted next-generation sequencing. This study analyzes a large patient cohort, supporting prior findings and revealing new melanoma genetics insights.

More Related Videos

A Robust Discovery Platform for the Identification of Novel Mediators of Melanoma Metastasis
07:41

A Robust Discovery Platform for the Identification of Novel Mediators of Melanoma Metastasis

Published on: March 8, 2022

3.0K
Comparative Lesions Analysis Through a Targeted Sequencing Approach
08:16

Comparative Lesions Analysis Through a Targeted Sequencing Approach

Published on: November 5, 2019

7.4K

Related Experiment Videos

Last Updated: Apr 18, 2026

Detecting Somatic Genetic Alterations in Tumor Specimens by Exon Capture and Massively Parallel Sequencing
11:02

Detecting Somatic Genetic Alterations in Tumor Specimens by Exon Capture and Massively Parallel Sequencing

Published on: October 18, 2013

20.1K
A Robust Discovery Platform for the Identification of Novel Mediators of Melanoma Metastasis
07:41

A Robust Discovery Platform for the Identification of Novel Mediators of Melanoma Metastasis

Published on: March 8, 2022

3.0K
Comparative Lesions Analysis Through a Targeted Sequencing Approach
08:16

Comparative Lesions Analysis Through a Targeted Sequencing Approach

Published on: November 5, 2019

7.4K

Area of Science:

  • Oncology
  • Genetics
  • Molecular Biology

Background:

  • Metastatic melanoma treatment increasingly relies on identifying targetable mutations.
  • Clinical genetic analysis has historically used single-gene Sanger sequencing.
  • Next-generation sequencing (NGS) offers a more comprehensive approach.

Purpose of the Study:

  • To evaluate the transition from Sanger sequencing to targeted NGS in clinical melanoma genetic analysis.
  • To present genetic data from a large cohort of advanced melanoma patients.
  • To identify novel genetic aspects of melanoma.

Main Methods:

  • Analysis of clinical genetic data from a large patient cohort with advanced melanoma.
  • Comparison of Sanger sequencing and targeted next-generation sequencing methodologies.
  • Bioinformatic analysis of sequencing data to identify mutations.

Main Results:

  • Data support previous findings regarding melanoma genetics.
  • Novel genetic findings in advanced melanoma patients were identified.
  • The study demonstrates the feasibility and utility of targeted NGS in clinical practice.

Conclusions:

  • Targeted next-generation sequencing represents a significant advancement in clinical genetic analysis for advanced melanoma.
  • The study provides valuable data on melanoma genetics, supporting current treatment strategies and opening new avenues for research.
  • The shift towards NGS facilitates a more comprehensive understanding of melanoma heterogeneity and potential therapeutic targets.